CONTOUR®NEXT ONE
Highly accurate results in seconds1

Are you ready to get started?

Why choose
CONTOUR®NEXT ONE?

Easy to use* with remarkably accurate results in seconds1

SmartlightTM provides a simple understanding of your blood glucose levels2

With Second-Chance® Sampling technology, you can save money with fewer wasted strips3

Download and connect to our free CONTOUR®DIABETES App** for an easy way to see and share your blood glucose results

Check to see if your smartphone’s operating system is compatible

Get started now
and SAVE!

DOWNLOAD COUPON >
BUY NOW >
REGISTER YOUR METER >

Related Products

CONTOUR®DIABETES App

LEARN MORE >

CONTOUR®NEXT Test Strips

LEARN MORE >

MICROLET® Lancets

LEARN MORE >

Chat With Us

Live support available to you
from 8:00 AM – 12:00 AM EDT
Monday to Sunday

START THE CHAT

Contact Us

Email: support@ContourNext.com

Phone: 1-800-348-8100 available
from 8:00 AM -12:00 AM EDT
Monday to Sunday.

Resources

 CONTOUR®NEXT ONE User Guide

–English

–Spanish

 CONTOUR®NEXT ONE Quick Reference Guide

–English

–Spanish

 How-To Videos

 FAQs

 CONTOUR®NEXT Meter Comparison Chart

*Before use please see the CONTOUR®NEXT ONE user guide for full instructions

**On a compatible Android or iOS device. For a list of compatible devices, please visit compatibility.contourone.com

1. Christiansen, M. P. (2017). A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology, 11(3), 567-573. DOI: 10.1177/1932296817691301.

2. Smartson online survey, Sweden 2017. 352 respondents: People with type 1 and type 2 diabetes, over 18 years old, who tested at least 4–7 times a day. Participants received free meter and tests strips. Survey funded by Ascensia Diabetes Care (Pg. 4).

3. Ascensia Diabetes Care. Data on File. Second Chance Sampling Research Topline Report, (May 2015). A 15-minute online study was conducted among people with diabetes (PWDs) and diabetes nurse educators (DNEs) in the US, UK and DE. PWDs and Pharmacists were the target in Canada. Hall & Partners.